Pubblicazione

Kim Lauper, Denis Mongin, Deshire Alpizar-Rodriguez et al.: Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution. Rheumatology, June 2019

Monika Hebeisen, Adrian Ciurea et al.: Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLOS|ONE, May 2019

Godehard A. Scholz, Alexander B. Leichtle, Burkhard Möller et al.: The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. British Journal of Haematology, April 2019

Alpizar-Rodriguez, A., Förger F. et al.: Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort. Rheumatology, Oct 2018

Lauper K., Mongin D., Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries. RMD Open, Sept. 2018

Oude Voshaar M. A. H., Dourvoisier D., van de Laar M.A.F.J. et al: Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric. Quality of Life Research, September 2018

Lechtenböhmer C.A., Hügle T. et al: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of concomitant Interphalangeal Joint Osteoarthritis. Arthritis and Rheumatology, August 2018

Didden E.M., Egger M., Finckh A. et al: Prediction of Real-World Drug Effectiveness Pre-Launch: Case Study in Rheumatoid Arthritis. Medical Decision Making, August 2018

Martinez-Prat L., Nissen M.J. et al: Comparison of serological Biomarkers in rheumatoid arthritis and their combination to improve Diagnostic Performance. Frontiers in Immunology, June 2018

Lauper K., Gabay C., et al: Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic DMARDs in patients with rheumatoid arthritis after the use of at least one biologic DMARD: analyses from the pan-European TOCERRA register collaboration. Ann Rheum Dis. May 2018; 0:1-7, doi: 10.1136/annrheumdis-2017-212845

Müller, R.B., von Kempis, J. et al: Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort. Rheumatic and muscosceletal diseases (RMD) open, May 2018

Hebeisen, M., Ciurea A., et al.: Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort. J Rheumatol. 2018 Apr;45(4):506-512. doi: 10.3899/jrheum.170166

Lauper K., Gabay C., et al: Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. Arthritis Care Res. Apr. 2018, doi: 10.1002/acr.23567

Heinimann, K., von Kempis, J., et al.: Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort. J Clin Med. 2018 Mar 13;7(3). pii: E57. doi: 10.3390/jcm7030057

Zufferey P., Ziswiler HR, A. et al: Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study. The Journal of Rheumatology 2018; 45:3; doi:10.3899/jrheum.161193

Molnar, C., Scherer, A. et al.: TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-211544. doi: 10.1136/annrheumdis-2017-211544. [Epub ahead of print]

Micheroli, R., Hebeisen, M., Ciurea, A. et al.: Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. Arthritis Res Ther. 2017 Jul 19;19(1):164. doi: 10.1186/s13075-017-1372-3.

Stekhoven, D., Scherer, A., Nissen, M.J. et al.: Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping. Clin Rheumatol (2017), doi:10.1007/s10067-017-3637-2, 22 April 2017

Chaigne B et Finckh A et al: Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life. Qual Life Res. 2017 Mar 11. doi: 10.1007/s11136-017-1534-4. [Epub ahead of print]

Chatzidionysiou K and Gabay C et al: Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration. J Rheumatol. 2017 Feb;44(2):162-169. doi: 10.3899/jrheum.160460. Epub 2017 Jan 15.